Decitabine - PDFSEARCH.IO - Document Search Engine

Decitabine
Results: 42

#	Item
1	Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma Add to Reading List Source URL: www.ehoonline.org Language: English Triazines Orphan drugs Acute leukemia Myeloid leukemia Azacitidine Acute myeloid leukemia Myelodysplastic syndrome Decitabine Leukemia Medicine Oncology Nucleosides
2	Eisai Inc. Receives Complete Response Letter from the U.S. Food and Drug Administration for Dacogen® (decitabine) for Injection sNDA in Acute Myeloid Leukemia DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc Add to Reading List Source URL: astx.com Language: English Myelodysplastic syndrome Syndromes Acute myeloid leukemia Eisai Neutropenia Decitabine Anemia Medicine Oncology Health
3	Astex Announces FDA ODAC Meeting of sNDA Application for Dacogen in Treatment of Elderly AML DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), today announced the pre-publication notice of the Add to Reading List Source URL: astx.com Language: English Syndromes Acute myeloid leukemia Leukemia Neutropenia Thrombocytopenia Decitabine Medicine Oncology Myelodysplastic syndrome
4	June 14, 2013 Astex Pharmaceuticals Announces Presentation of Updated Results of SGI[removed]Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology As Add to Reading List Source URL: astx.com Language: English Oncology Orphan drugs Myelodysplastic syndrome Syndromes Azacitidine Decitabine Cyclacel Medicine Nucleosides Triazines
5	Eisai and Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia Data from DACO-016 study at 2011 American Society of Clinical Oncology Ann Add to Reading List Source URL: astx.com Language: English Myeloid leukemia Acute leukemia Acute myeloid leukemia Myelodysplastic syndrome Cytarabine Decitabine Leukemia Neutropenia Lintuzumab Oncology Medicine Nucleosides
6	July 8, 2013 Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator Investigational New Drug (IND) Application and Data Presentations Planned for the Fourth Quarter DUBLIN, Add to Reading List Source URL: astx.com Language: English Clinical research Pharmaceutical industry Food and Drug Administration Astex Eisai Decitabine Hypomethylating agent Clinical trial Drug discovery Pharmaceutical sciences Pharmacology Medicine
7	FDA Accepts DACOGEN(R) (Decitabine) sNDA Submission in Acute Myeloid Leukemia DUBLIN, Calif., Jul 13, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and developmen Add to Reading List Source URL: astx.com Language: English Myelodysplastic syndrome Syndromes Acute myeloid leukemia Leukemia Thrombocytopenia Neutropenia Cytarabine Anemia Medicine Oncology Hematopathology
8	Astex Pharmaceuticals Announces Subcutaneous SGI-110 Interim Phase 1/2 MDS and AML Data Presentation at AACR DUBLIN, Calif., April 3, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical c Add to Reading List Source URL: astx.com Language: English Acute myeloid leukemia Myeloid leukemia Myelodysplastic syndrome Astex Decitabine Oncology Medicine Acute leukemia
9	Comparison of the Efficacy and Safety of 5-day and 10day schedules of SGI-110, a novel subcutaneous (SC) hypomethylating agent (HMA), in the treatment of relapsed/refractory Acute Myeloid Leukemia (r/r AML) Gail J. Roboz Add to Reading List Source URL: astx.com Language: English Acute myeloid leukemia Myeloid leukemia MG Cars Decitabine Hypomethylating agent Oncology Medicine Acute leukemia
10	Abst. No. Outcomes of Intermediate or High Risk Myelodysplastic Syndromes (MDS) Patients Post Azacitidine and/or Decitabine Treatment Failures with SGI-110, a Novel Second Generation Hypomethylating Agent (HMA) Add to Reading List Source URL: astx.com Language: English Triazines Orphan drugs Azacitidine lactams Myelodysplastic syndrome Decitabine Hypomethylating agent Lenalidomide Acute myeloid leukemia Medicine Oncology Nucleosides

UPDATE